27 results on '"Drew H. Barzman"'
Search Results
2. 2.1 Using Artificial Intelligence to Identify Risk of School Violence
- Author
-
Drew H. Barzman and Yizhao Ni
- Subjects
Psychiatry and Mental health ,Applied psychology ,Developmental and Educational Psychology ,School violence ,Psychology - Published
- 2021
3. Finding Warning Markers: Leveraging Natural Language Processing and Machine Learning Technologies to Detect Risk of School Violence
- Author
-
Alexander J. Osborn, Michael T. Sorter, Alycia Bachtel, Drew H. Barzman, Marcus Griffey, and Yizhao Ni
- Subjects
Male ,020205 medical informatics ,Adolescent ,Population ,education ,Poison control ,Health Informatics ,Feature selection ,02 engineering and technology ,Violence ,Machine learning ,computer.software_genre ,Suicide prevention ,Risk Assessment ,Occupational safety and health ,Article ,Machine Learning ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Injury prevention ,0202 electrical engineering, electronic engineering, information engineering ,Humans ,030212 general & internal medicine ,Prospective Studies ,Child ,Students ,Natural Language Processing ,education.field_of_study ,business.industry ,Human factors and ergonomics ,Female ,Artificial intelligence ,Risk assessment ,Psychology ,business ,computer ,Natural language processing ,Algorithms - Abstract
INTRODUCTION: School violence has a far-reaching effect, impacting the entire school population including staff, students and their families. Among youth attending the most violent schools, studies have reported higher dropout rates, poor school attendance, and poor scholastic achievement. It was noted that the largest crime-prevention results occurred when youth at elevated risk were given an individualized prevention program. However, much work is needed to establish an effective approach to identify at-risk subjects. OBJECTIVE: In our earlier research, we developed a risk assessment program to interview subjects, identify risk and protective factors, and evaluate risk for school violence. This study focused on developing natural language processing (NLP) and machine learning technologies to automate the risk assessment process. MATERIAL AND METHODS: We prospectively recruited 131 students with or without behavioral concerns from 89 schools between 05/01/2015 and 04/30/2018. The subjects were interviewed with two risk assessment scales and a questionnaire, and their risk of violence were determined by pediatric psychiatrists based on clinical judgment. Using NLP technologies, different types of linguistic features were extracted from the interview content. Machine learning classifiers were then applied to predict risk of school violence for individual subjects. A two-stage feature selection was implemented to identify violence-related predictors. The performance was validated on the psychiatrist-generated reference standard of risk levels, where positive predictive value (PPV), sensitivity (SEN), negative predictive value (NPV), specificity (SPEC) and area under the ROC curve (AUC) were assessed. RESULTS: Compared to subjects’ sociodemographic information, use of linguistic features significantly improved classifiers’ predictive performance (P
- Published
- 2020
4. Automated Risk Assessment for School Violence: a Pilot Study
- Author
-
Kenneth Lin, Yizhao Ni, Melissa P. DelBello, Drew H. Barzman, Michael T. Sorter, Hannah Jackson, Marcus Griffey, and Alycia Bachtel
- Subjects
Male ,050103 clinical psychology ,Adolescent ,education ,Poison control ,Violence ,Risk Assessment ,Suicide prevention ,Occupational safety and health ,Machine Learning ,03 medical and health sciences ,0302 clinical medicine ,Injury prevention ,Humans ,Outpatient clinic ,0501 psychology and cognitive sciences ,030212 general & internal medicine ,Child ,Socioeconomic status ,Natural Language Processing ,Schools ,05 social sciences ,Human factors and ergonomics ,Aggression ,Psychiatry and Mental health ,Adolescent Behavior ,Female ,Risk assessment ,Psychology ,Clinical psychology - Abstract
School violence has increased over the past ten years. This study evaluated students using a more standard and sensitive method to help identify students who are at high risk for school violence. 103 participants were recruited through Cincinnati Children’s Hospital Medical Center (CCHMC) from psychiatry outpatient clinics, the inpatient units, and the emergency department. Participants (ages 12–18) were active students in 74 traditional schools (i.e. non-online education). Collateral information was gathered from guardians before participants were evaluated. School risk evaluations were performed with each participant, and audio recordings from the evaluations were later transcribed and manually annotated. The BRACHA (School Version) and the School Safety Scale (SSS), both 14-item scales, were used. A template of open-ended questions was also used. This analysis included 103 participants who were recruited from 74 different schools. Of the 103 students evaluated, 55 were found to be moderate to high risk and 48 were found to be low risk based on the paper risk assessments including the BRACHA and SSS. Both the BRACHA and the SSS were highly correlated with risk of violence to others (Pearson correlations>0.82). There were significant differences in BRACHA and SSS total scores between low risk and high risk to others groups (p-values
- Published
- 2018
5. PREDICTING THE FUTURE? UNDERSTANDING AGGRESSION RATING SCALES IN ACUTE CARE SETTINGS AND HOW TO UTILIZE THIS KNOWLEDGE
- Author
-
Drew H. Barzman, Meghan M. Schott, Michael T. Sorter, and Nicole Figueroa
- Subjects
Psychiatry and Mental health ,medicine.medical_specialty ,Aggression ,Rating scale ,Acute care ,Developmental and Educational Psychology ,medicine ,medicine.symptom ,Psychology ,Clinical psychology - Published
- 2021
6. Beyond DSM-5 and IQ Scores: Integrating the Four Pillars to Forensic Evaluations
- Author
-
Drew H. Barzman and Sergio V. Delgado
- Subjects
media_common.quotation_subject ,Applied psychology ,Theory of Mind ,Social Environment ,050105 experimental psychology ,DSM-5 ,Developmental psychology ,03 medical and health sciences ,Cognition ,0302 clinical medicine ,030225 pediatrics ,Theory of mind ,Interview, Psychological ,Humans ,Personality ,Mental Competency ,0501 psychology and cognitive sciences ,Temperament ,Competence (human resources) ,media_common ,Intelligence Tests ,Psychodynamic psychotherapy ,05 social sciences ,Forensic Psychiatry ,Object Attachment ,Diagnostic and Statistical Manual of Mental Disorders ,Psychiatry and Mental health ,Psychology ,Intersubjectivity - Abstract
The current adult and child forensic psychiatrist is well trained, familiar, and comfortable with the use of the semi-structured Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, APA 2013 (DSM-5) [In APA, 2003] interview style. The author's assertion is not that this method is invalid or unreliable; rather, that it can be complemented by integrating elements of the defendant's four pillar assessment. Assessing the four pillars expands on the information provided by a semi-structured DSM-5-style interview in psychiatry. The four pillars are the foundation of a person's personality; temperament, cognition (learning abilities or weaknesses), cognitive flexibility (theory of mind) and internal working models of attachment, within the backdrop of the family and of the social and cultural environment in which they have lived. The importance of the study of four pillars is based on the understanding that human behavior and psychopathology as a complex and multifaceted process that includes the level of social-emotional maturity and cognitive abilities (In Delgado et al. Contemporary Psychodynamic Psychotherapy for Children and Adolescents: Integrating Intersubjectivity and Neuroscience. Springer, Berlin, 2015). The four pillars are not new concepts, rather they had been studied by separate non-clinical disciplines, and had not been integrated to the clinical practice. As far as we know, it wasn't until Delgado et al. (Contemporary Psychodynamic Psychotherapy for Children and Adolescents: Integrating Intersubjectivity and Neuroscience. Springer, Berlin, 2015) incorporated the four pillars in a user-friendly manner to clinical practice.
- Published
- 2016
7. Eye Gaze Patterns Associated with Aggressive Tendencies in Adolescence
- Author
-
Drew H. Barzman, Ernest V. Pedapati, Cameron S. Laue, Ping-I Lin, Kirk Wallace, Paul S. Horn, Marcus Griffey, Menno van der Schoot, Educational Studies, and LEARN! - Brain, learning and development
- Subjects
Male ,050103 clinical psychology ,Time Factors ,Adolescent ,Hostility ,Fixation, Ocular ,Social information processing ,Social cognition ,medicine ,Humans ,0501 psychology and cognitive sciences ,Interpersonal Relations ,Social information ,Social Behavior ,Psychiatric Status Rating Scales ,Aggression ,05 social sciences ,Eye movement ,Aggressive behavior ,Psychiatry and Mental health ,Social Perception ,Linear Models ,Eye tracking ,Female ,medicine.symptom ,Eye-tracking ,Psychology ,Attribution ,050104 developmental & child psychology ,Cognitive psychology - Abstract
Social information processing theory hypothesizes that aggressive children pay more attention to cues of hostility and threat in others’ behavior, consequently leading to over-interpretation of others’ behavior as hostile. While there is abundant evidence of aggressive children demonstrating hostile attribution biases, less well documented is whether such biases stem from over-attendance and hypersensitivity to hostile cues in social situations. Over-attendance to hostile cues would be typified by deviations at any stage of the multi-stage process of social information processing models. While deviations at later stages in social information processing models are associated with aggressive behavior in children, the initial step of encoding has historically been difficult to empirically measure, being a low level automatic process unsuitable for self-report. We employed eye-tracking methodologies to better understand the visual encoding of such social information. Eye movements of ten 13–18 year-old children referred from clinical and non-clinical populations were recorded in real time while the children viewed scenarios varying between hostile, non-hostile and ambiguous social provocation. In addition, the children completed a brief measure of risk of aggression. Aggressive children did attend more to the social scenarios with hostile cues, in particular attending longest to those hostile scenarios where the actor in the scenario had a congruent emotional response. These findings corroborate social information processing theory and the traditional bottom-up processing hypotheses that aggressive behavior relates to increased attention to hostile cues.
- Published
- 2018
8. Correlations of inflammatory gene pathways, corticolimbic functional activities, and aggression in pediatric bipolar disorder: A preliminary study
- Author
-
Michele Durling, Drew H. Barzman, Pablo Abonia, Jim Eliassen, Douglas Mossman, Melissa P. DelBello, Caleb M. Adler, Robert K. McNamara, and Ping-I Lin
- Subjects
Male ,Bipolar Disorder ,Adolescent ,Neuroscience (miscellaneous) ,Poison control ,Brodmann area 10 ,Gyrus Cinguli ,Brain mapping ,Amygdala ,Article ,Thalamus ,Surveys and Questionnaires ,medicine ,Humans ,Gene Regulatory Networks ,Radiology, Nuclear Medicine and imaging ,Bipolar disorder ,Child ,Prefrontal cortex ,Cerebral Cortex ,Brain Mapping ,Aggression ,Brain ,medicine.disease ,Magnetic Resonance Imaging ,Psychiatry and Mental health ,medicine.anatomical_structure ,Female ,Orbitofrontal cortex ,medicine.symptom ,Psychology ,Neuroscience ,psychological phenomena and processes ,Clinical psychology - Abstract
The mechanisms underlying aggression in adolescents with bipolar disorder have been poorly understood. The present study has investigated the associations among TNF gene expressions, functional brain activations under the frustrative non-reward task, and aggression in adolescents with bipolar disorder. Baseline gene expressions and aggressive tendencies were measured with the RNA-sequencing and Brief Rating of Aggression by Children and Adolescents (BRACHA), respectively. Our results show that activity levels of left subgenual anterior cingulate gyrus (ACG) right amygdala, left Brodmann area 10 (orbitofrontal cortex), and right thalamus were inversely correlated with BRACHA scores and were activated with frustrative non-reward during the affective Posner Task. In addition, eleven TNF related gene expressions were significantly correlated with activation of amygdala or ACG during the affective Posner task. Three TNF gene expressions were inversely correlated with BRACHA score while one TNF gene (TNFAIP3) expression was positively correlated with BRACHA score. Therefore, TNF-related inflammatory cytokine genes may play a role in neural activity associated with frustrative non-reward and aggressive behaviors in pediatric bipolar disorder.
- Published
- 2014
9. Conduct Disorder and Its Clinical Management
- Author
-
Drew H. Barzman and Bianca Patel
- Subjects
medicine.medical_specialty ,Conduct disorder ,mental disorders ,medicine ,Psychiatry ,medicine.disease ,Psychology - Abstract
Conduct disorder (CD), a psychiatric condition that is prevalent in some child and adolescent populations, is defined by the DSM-5 as a repetitive and persistent pattern of behavior in which the rights of others and age-appropriate cultural norms are violated. DSM-5 subtypes include childhood-onset, adolescent-onset, and callous-unemotional presentations. The development of CD is affected by gender, age at onset, environmental factors, and genetic factors. Overall, it has been difficult to identify causative factors because there is such a diverse variety of factors and comorbidities involved, although studies to define specific genetic, physiologic, and neurologic links to CD are ongoing. Common comorbidities in CD include oppositional defiant disorder, attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, bipolar disorder, dysthymia, and substance abuse. The most successful treatment involves a multisystemic approach involving medication, family therapy, educational therapy, and parenting skills. Overall, early prevention of CD through treatment is key because the prognosis is poor and can be associated with the development of more severe comorbidities. This review contains 3 tables, and 58 references. Key words: antisocial behavior behavioral issues, ADHD comorbidities, child mental disorders, conduct disorder
- Published
- 2017
10. The impact of ADHD on morality development
- Author
-
Drew H. Barzman and Cory M. J. Groman
- Subjects
media_common.quotation_subject ,Perspective (graphical) ,Social change ,General Medicine ,Morality ,Affect (psychology) ,Object Attachment ,behavioral disciplines and activities ,Child development ,Moral Development ,Developmental psychology ,Psychiatry and Mental health ,Clinical Psychology ,Child Development ,Moral development ,Attention Deficit Disorder with Hyperactivity ,mental disorders ,Psychological Theory ,Attachment theory ,Humans ,Child ,Psychology ,media_common - Abstract
Attention deficit hyperactive disorder (ADHD) is one of the most commonly diagnosed childhood mental disorders. This pervasive disorder can affect all aspects of the child's life, including, but not limited to: peer relations, adult relations and intellectual development. As a direct result of ADHD, many of these deficiencies pervade through the child's life into adulthood. Although there is a growing number of literature focusing on the sequela of ADHD, especially social deviance, most of the literature's scope is limited to the connection between ADHD and criminality. This finite perspective provides little insight into the developmental characteristics which actually link ADHD to criminality. The most glaring example of an obscured developmental link is that of moral judgment. The following is an attempt to draw a meaningful connection between deficient moral development and ADHD, especially as it relates to attachment theory. Connecting previous research relevant to the topic as well as time-tested psychological theories on morality and attachment will serve to validate this claim.
- Published
- 2014
11. The Association Between Salivary Hormone Levels and Children’s Inpatient Aggression: A Pilot Study
- Author
-
Bianca Patel, Michael T. Sorter, Drew H. Barzman, Kacey Appel, Douglas Mossman, Jeffrey R. Strawn, Thomas D. Geracioti, Nosa N. Ekhator, David J. Klein, Melissa P. DelBello, and Thomas J. Blom
- Subjects
Male ,medicine.medical_specialty ,Saliva ,Time Factors ,Adolescent ,Hydrocortisone ,Child Behavior ,Aggression Scale ,Poison control ,Enzyme-Linked Immunosorbent Assay ,Pilot Projects ,Violence ,Upon Awakening ,Risk Assessment ,Predictive Value of Tests ,Surveys and Questionnaires ,Internal medicine ,Injury prevention ,Child and adolescent psychiatry ,medicine ,Humans ,Child ,Androstenols ,Inpatients ,Aggression ,Testosterone (patch) ,Hospitalization ,Psychiatry and Mental health ,Feasibility Studies ,medicine.symptom ,Psychology ,Biomarkers ,Clinical psychology - Abstract
Aggression is a common management problem for child psychiatry hospital units. We describe an exploratory study with the primary objective of establishing the feasibility of linking salivary concentrations of three hormones (testosterone, dehydroepiandrosterone [DHEA], and cortisol) with aggression. Between May 2011 and November 2011, we recruited 17 psychiatrically hospitalized boys (age 7–9 years). We administered the Brief Rating of Aggression by Children and Adolescents (BRACHA) and Predatory-Affective Aggression Scale (PAAS) upon admission. Saliva samples were collected from the participants during a 24-h period shortly after admission: immediately upon awakening, 30 min later, and again between 3:45 and 7:45 P.M. Nursing staff recorded Overt Aggression Scale ratings twice a day during hospitalization to quantify aggressive behavior. The salivary cortisol concentrations obtained from aggressive boys 30 min after awakening trended higher than levels from the non-aggressive boys (p = 0.06), were correlated with the number of aggressive incidents (p = 0.04), and trended toward correlation with BRACHA scores (p = 0.06). The aggressive boys also showed greater morning-to-evening declines in cortisol levels (p = 0.05). Awakening levels of DHEA and testosterone were correlated with the severity of the nearest aggressive incident (p < 0.05 for both). The BRACHA scores of the aggressive boys were significantly higher than scores of the non-aggressive boys (p < 0.001). Our data demonstrate the feasibility of collecting saliva from children on an inpatient psychiatric unit, affirm the utility of the BRACHA in predicting aggressive behavior, and suggest links between salivary hormones and aggression by children who undergo psychiatric hospitalization.
- Published
- 2013
12. Pharmacology and Pharmacogenetics of Pediatric ADHD with Associated Aggression: A Review
- Author
-
Drew H. Barzman and Bianca Patel
- Subjects
medicine.medical_specialty ,Adolescent ,Poison control ,Atomoxetine Hydrochloride ,Impulsivity ,mental disorders ,medicine ,Humans ,Attention deficit hyperactivity disorder ,Precision Medicine ,Child ,Psychiatry ,Psychotropic Drugs ,Adrenergic Uptake Inhibitors ,Propylamines ,Aggression ,Methylphenidate ,Atomoxetine ,medicine.disease ,Psychiatry and Mental health ,Treatment Outcome ,Attention Deficit Disorder with Hyperactivity ,Pharmacogenetics ,Impulsive Behavior ,Central Nervous System Stimulants ,medicine.symptom ,Psychology ,Adrenergic alpha-Agonists ,Atomoxetine hydrochloride ,Clinical psychology ,medicine.drug - Abstract
Attention deficit hyperactivity disorder (ADHD) is often associated with symptoms of aggression in children and adolescents. Clinically, this is complex because aggression can be from hyperactivity and impulsivity, or could be a distinct symptom from a comorbid diagnosis. Past research has recommended first treating the primary disorder of ADHD. Stimulants are the most common treatment for pediatric ADHD, which can be helpful in decreasing aggressive behaviors. Alpha-adrenergic agonists and atomoxetine (ATX) are non-stimulant medications for ADHD and aggression, but more research is necessary to compare these drugs to stimulants. If aggressive symptoms do not improve from treating the primary disorder, aggression can be treated separately. Risperidone, lithium, valproic acid, clonidine, and guanfacine have shown positive results in reducing aggression, but studies including children with aggression and ADHD are limited. The variability in treatment tolerability in patients has stimulated research in pharmacogenetics for ADHD. Although this field is still emerging, research has found evidence supporting a link between the response rate of methylphenidate and the dopamine transporter (DAT1) and a link between the metabolism rate of atomoxetine and hepatic cytochrome 450 isozymes. Pharmacogenetics may be relevant to ADHD and associated aggression. Further research in pharmacogenetics will strive to identify patterns of genetic variations that can tailor individual treatments.
- Published
- 2013
13. Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania
- Author
-
Melissa P. DelBello, Jeffrey A. Welge, Caleb M. Adler, Lawrence J. Saliba, James C. Eliassen, Stephen M. Strakowski, Drew H. Barzman, Jeffrey R. Strawn, Robert K. McNamara, Marguerite Reid Schneider, Wade Weber, and L. Rodrigo Patino
- Subjects
Adult ,Male ,Risk ,medicine.medical_specialty ,Ventrolateral prefrontal cortex ,Bipolar I disorder ,Bipolar Disorder ,Adolescent ,Prefrontal Cortex ,Audiology ,Amygdala ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Child of Impaired Parents ,Developmental and Educational Psychology ,medicine ,Humans ,Bipolar disorder ,Psychiatry ,Child ,Anterior cingulate cortex ,medicine.diagnostic_test ,medicine.disease ,Magnetic Resonance Imaging ,030227 psychiatry ,Psychiatry and Mental health ,medicine.anatomical_structure ,Female ,medicine.symptom ,Psychology ,Functional magnetic resonance imaging ,Mania ,030217 neurology & neurosurgery ,Brodmann area - Abstract
Objective To examine prefrontal and amygdala activation during emotional processing in youth with or at varying risk for developing mania to identify candidate central prodromal risk biomarkers. Method Four groups of medication-free adolescents (10–20 years old) participated: adolescents with first-episode bipolar I disorder (BP-I; n = 32), adolescents with a parent with bipolar disorder and a depressive disorder (at-risk depressed [ARD]; n = 32), healthy adolescents with a parent with bipolar disorder (at-risk healthy [ARH]; n = 32), and healthy adolescents with no personal or family history of psychiatric illness (healthy comparison [HC]; n = 32). Participants underwent functional magnetic resonance imaging while performing a continuous performance task with emotional and neutral distracters. Region-of-interest analyses were performed for the bilateral amygdala and for subregions of the ventrolateral prefrontal cortex and anterior cingulate cortex. Results Overall, no group differences in bilateral amygdala and ventrolateral prefrontal cortex (Brodmann area [BA] 45/47) activation during emotional or neutral stimuli were observed. The BP-I group exhibited lower right pregenual anterior cingulate cortex activation compared with the HC group, and activation in the left BA 44 was greater in the ARH and ARD groups compared with the HC group. BP-I and ARD groups exhibited blunted activation in the right BA 10 compared with the ARH group. Conclusion During emotional processing, amygdala and ventrolateral prefrontal cortex (BA 45/47) activation does not differ in youth with or at increasing risk for BP-I. However, blunted pregenual anterior cingulate cortex activation in first-episode mania could represent an illness biomarker, and greater prefrontal BA 10 and BA 44 activations in at-risk youth could represent a biomarker of risk or resilience warranting additional investigation in prospective longitudinal studies.
- Published
- 2015
14. Childhood Cruelty to Animals: Psychiatric and Demographic Correlates
- Author
-
Jaclyn E. Barnes, Drew H. Barzman, Erica S. Pearl, Frank W. Putnam, Linda Richey, Barbara W. Boat, and Denise Crouch
- Subjects
medicine.medical_specialty ,Acting out ,Aggression ,medicine.medical_treatment ,Animal-assisted therapy ,Cruelty ,Health Professions (miscellaneous) ,Mental health ,Psychiatry and Mental health ,Clinical Psychology ,Sexual abuse ,Animal welfare ,medicine ,Cruelty to animals ,medicine.symptom ,Psychiatry ,Psychology ,Clinical psychology - Abstract
This retrospective study compared frequencies of aggressive behaviors and abuse histories noted during a psychiatric intake assessment for children where animal cruelty was endorsed and a control sample of youth for whom animal cruelty was not endorsed to determine if rates of concerning behaviors differed significantly. Relative to the control group, the cruelty group was significantly more likely to have had problems with peers, perpetrated bullying, experienced sexual abuse, and have a history of sexually acting out. Recommendations for childhood animal cruelty screening in mental health settings are discussed.
- Published
- 2011
15. 5.57 Development of Artificial Intelligence to Predict School Violence
- Author
-
Kenneth Lin, Marcus Griffey, Shivani Dighamber, Alycia Bachtel, Drew H. Barzman, Melissa P. DelBello, Michael T. Sorter, and Yizhao Ni
- Subjects
Psychiatry and Mental health ,Applied psychology ,Developmental and Educational Psychology ,Psychology ,School violence - Published
- 2018
16. Rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder
- Author
-
Heather D. Lehmkuhl, David E. Fleck, Melissa P. DelBello, Stephen M. Strakowski, and Drew H. Barzman
- Subjects
Adult ,Conduct Disorder ,Male ,medicine.medical_specialty ,Bipolar Disorder ,Adolescent ,Sexual Behavior ,Statistics as Topic ,Poison control ,Comorbidity ,Risk Factors ,Injury prevention ,Juvenile delinquency ,medicine ,Humans ,Longitudinal Studies ,Bipolar disorder ,Child ,Psychiatry ,Biological Psychiatry ,Ohio ,Incidence (epidemiology) ,Age Factors ,Antisocial Personality Disorder ,medicine.disease ,Anxiety Disorders ,Hospitalization ,Psychiatry and Mental health ,Cross-Sectional Studies ,Juvenile Delinquency ,Anxiety ,Central Nervous System Stimulants ,Female ,Crime ,medicine.symptom ,Psychology ,Psychosocial ,Mania ,Clinical psychology - Abstract
Barzman DH, DelBello MP, Fleck DE, Lehmkuhl H, Strakowski SM. Rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder. Bipolar Disord 2007: 9: 339-344. © Blackwell Munksgaard, 2007 Objectives: To examine the rates, types, and psychosocial correlates of legal charges in adolescents with newly diagnosed bipolar disorder (BD). Methods: Adolescents (n = 80), between the ages of 12 and 21 years (mean = 15.6, standard deviation - 2.3), hospitalized for their initial manic or mixed episode of BD, were evaluated for the incidence of prior juvenile offending (i.e., legal charges). We examined potential psychosocial correlates associated with legal charges using chi-square, (t-tests, and discriminant function analyses to determine if there were differences between adolescents who did and did not offend prior to their first manic episode. Results: Juvenile antisocial behaviors were common (55%) for adolescents with newly diagnosed BD. Discriminant function analysis revealed that older age at first treatment (p < 0.01), sexual activity over the previous month (p < 0.05), therapeutic use of stimulants (p < 0.05), and anxiety disorders were the most significant factors to differentiate between bipolar adolescents who offended and those who did not (Wilks' lambda = 0.80, p < 0.005). Conclusions: Our findings indicate that there are identifiable psychosocial correlates associated with antisocial behaviors in adolescents with newly diagnosed BD that may improve our understanding of juvenile antisocial behaviors.
- Published
- 2007
17. Disentangling Cognitive Defects in Chronic Depression and Repetitive Mild Traumatic Brain Injury
- Author
-
Drew H Barzman and Ping-I Lin
- Subjects
medicine.medical_specialty ,Cognitive defects ,Traumatic brain injury ,Chronic depression ,Cognition ,Audiology ,medicine.disease ,Temporal lobe ,Visual processing ,medicine ,Psychology ,Psychiatry ,Cognitive impairment ,Depression (differential diagnoses) - Abstract
Patients with chronic depression may suffer from global cognitive defects. Here, we present a case with repetitive mild traumatic brain injuries (mTBI) that aggravated her depressive symptoms and exhibited atypical cognitive impairments. Her depressive symptoms had been resistant to a combination of SNRI and antipsychotics. The single-photon emission computed tomography scan showed asymmetric perfusion at medial temporal lobes - which has been found to be associated with somatic delusions in some other patients. Her cognitive impairment profile was also consistent with difficulty in inhibition and visual processing, as noted in medial temporal lobe dysfunction, but not commonly seen in chronic depression. After her depression was improved with antipsychotic medications, her specific cognitive impairments persisted. To conclude, repetitive mTBI might cause selective or atypical cognitive impairments that impact treatment responses in patients with depressive disorders.
- Published
- 2015
18. The Efficacy and Tolerability of Quetiapine versus Divalproex for the Treatment of Impulsivity and Reactive Aggression in Adolescents with Co-Occurring Bipolar Disorder and Disruptive Behavior Disorder(s)
- Author
-
Drew H. Barzman, Stephen M. Strakowski, Melissa P. DelBello, Caleb M. Adler, and Kevin E. Stanford
- Subjects
Divalproex ,Dibenzothiazepines ,medicine.medical_specialty ,Bipolar Disorder ,Bipolar I disorder ,Adolescent ,Poison control ,Impulsivity ,Quetiapine Fumarate ,Double-Blind Method ,Antimanic Agents ,mental disorders ,medicine ,Humans ,Pharmacology (medical) ,Bipolar disorder ,Child ,Psychiatry ,Valproic Acid ,medicine.disease ,Aggression ,Psychiatry and Mental health ,Attention Deficit Disorder with Hyperactivity ,Attention Deficit and Disruptive Behavior Disorders ,Conduct disorder ,Impulsive Behavior ,Pediatrics, Perinatology and Child Health ,Quetiapine ,medicine.symptom ,Psychology ,Antipsychotic Agents ,Clinical psychology ,medicine.drug - Abstract
The aim of this study was to compare the efficacy and tolerability of quetiapine and divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorders.Patients were included in this post hoc analysis if they scoredor = 14 on the Positive and Negative Syndrome Scale (PANSS) Excited Component (EC) andor = 4 on at least one of the PANSS EC items, had a current diagnosis of bipolar I disorder, manic or mixed episode, and had a lifetime and/or current diagnosis of a disruptive behavioral disorder (DBD) [conduct disorder (CD) or oppositional defiant disorder (ODD)]. Thirty-three (92%) of the 36 subjects with bipolar disorder and DBD met the PANSS EC inclusion criteria. These thirty-three adolescents were randomized to quetiapine (400-600 mg/day) or divalproex (serum level 80-120 microg/mL) for 28 days in this double-blinded study. The primary efficacy measure was change in PANSS Excited Component (EC) score over the study period and at each time point.Repeated measures analysis of variance (ANOVA) demonstrated statistically significant within-treatment-group effects for divalproex (baseline = 20.6, end point = 13.3, p0.0001) and quetiapine (baseline = 18.8, end point = 10.8, p0.0001) for the PANSS EC. There were no statistically significant treatment group differences in PANSS EC changes from baseline to end point scores (p = 0.7, d = 0.14). Mixed regression analyses (comparison of slopes, DAY*TREATMENT) revealed that there was no significant difference in the rate of improvement in the PANSS EC scores between the two treatment groups [F(1,31) = 0.78, p = 0.39, d = 0.28].Quetiapine and divalproex showed similar efficacy for the treatment of impulsivity and reactive aggression related to co-occurring bipolar and disruptive behavior disorders in adolescents. Quetiapine and divalproex are both useful as monotherapy for the treatment of impulsivity and reactive aggression in adolescents with bipolar and disruptive behavior disorders. Placebo-controlled studies are necessary.
- Published
- 2006
19. Impulsive aggression with irritability and responsive to divalproex: A pediatric bipolar spectrum disorder phenotype?
- Author
-
Gopalan Sethuraman, Ann-Marie Kahwaty, Drew H. Barzman, Krissell Moore, Brian J. McConville, Daniel A. Nelson, Brian Masterson, and Susan L. McElroy
- Subjects
Male ,Divalproex ,Bipolar Disorder ,Adolescent ,medicine.drug_class ,Aggression Scale ,Poison control ,Irritability ,Antimanic Agents ,medicine ,Humans ,Spectrum disorder ,Bipolar disorder ,Child ,Retrospective Studies ,Inpatients ,Aggression ,Valproic Acid ,Mood stabilizer ,medicine.disease ,Irritable Mood ,Psychiatry and Mental health ,Clinical Psychology ,Phenotype ,Treatment Outcome ,Impulsive Behavior ,Female ,medicine.symptom ,Psychology ,Clinical psychology - Abstract
Background The objective of this retrospective chart review was to evaluate the phenomenology and response to divalproex in a sub-population of children admitted to an inpatient setting with severe impairing symptoms of irritability and aggression. In addition, we examined whether the symptomatology of this group was consistent with a pediatric divalproex-responsive bipolar spectrum disorder. Methods The charts of 46 child and adolescent patients with prominent impulsive aggression with irritability admitted to a crisis stabilization center were assessed retrospectively. Impulsive aggressive symptoms were assessed for admission and discharge severity by two clinicians using the Overt Aggression Scale (OAS) and the Anger-Hostility Subscale of the SCL-90 (SCL-A), with overall functioning changes assessed using the Children's Global Assessment Scale (C-GAS). Results Statistically significant improvements were obtained for the group in the C-GAS, with significant decreases in the OAS and the SCL-A scores at discharge, following a maximal 14-day stay. No severe side effects were reported. All patients met the criteria for a potential pediatric bipolar phenotype. Limitations This was a retrospective study without randomization or a control group. Additionally, the non-blinded design may have biased the raters concerning the effectiveness of divalproex for impulsive aggression. Conclusions Our data are in line with divalproex response in children and adolescents with target symptoms of explosive temper and mood instability. Our data further suggest that such symptoms, coupled with impulsive aggression and irritability, as well as related manic symptoms, constitute a pediatric divalproex-responsive bipolar spectrum disorder.
- Published
- 2005
20. The Effectiveness and Tolerability of Aripiprazole for Pediatric Bipolar Disorders: A Retrospective Chart Review
- Author
-
Stephen M. Strakowski, Pamela Campbell, Robert A. Kowatch, Sergio V. Delgado, Melissa P. DelBello, Beth Gernert, Sanjeev Pathak, Katherine Rappaport, Drew H. Barzman, and David E. Fleck
- Subjects
Adult ,Male ,medicine.medical_specialty ,Bipolar Disorder ,Adolescent ,Treatment outcome ,Aripiprazole ,MEDLINE ,Quinolones ,Piperazines ,Chart review ,medicine ,Humans ,Pharmacology (medical) ,Child ,Psychiatry ,Retrospective Studies ,Psychiatric Status Rating Scales ,Retrospective cohort study ,humanities ,body regions ,Psychiatry and Mental health ,Treatment Outcome ,Psychotic Disorders ,Tolerability ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Psychiatric status rating scales ,Female ,Psychology ,Antipsychotic Agents ,medicine.drug - Abstract
The aim of this retrospective chart review was to evaluate the effectiveness and tolerability of aripiprazole for the treatment of children and adolescents with bipolar disorders.The medical charts of all children and adolescents with a DSM-IV diagnosis of bipolar disorder, type I, type II, not otherwise specified (NOS), or schizoaffective disorder, bipolar type, and who were treated with aripiprazole were reviewed by two child and adolescent psychiatrists who independently confirmed their DSM-IV diagnoses, severity, and the improvement of illness using the Clinical Global Impression (CGI) Severity and Improvement scores for bipolar disorder (CGI-BP) and the Clinical Global Assessment Scale (CGAS).Thirty patients who were treated with aripiprazole were identified (mean starting dose=9 +/- 4 mg/day, mean final dose=10 +/- 3 mg/day). The overall response rate, defined by a CGI-Improvement score ofor = 2 at endpoint, was 67%. There was a statistically significant improvement in CGAS scores (48 +/- 11 to 65 +/- 11, signed rank = 191, p0.0001) and CGI-S scores (4.2 +/- 0.8 to 2.8 +/- 1.0, signed rank=-172, p0.0001, effect size=1.90) from baseline to endpoint. No serious adverse events were identified. Common side effects were sedation (n=10, 33%), akathisia (n=7, 23%), and gastrointestinal disturbances (n=2, 7%). Baseline and endpoint weights were available for 14 (47%) of the patients. Change in weight ranged from +5 to -21 kg and 12 (86%) of 14 patients lost weight (mean weight loss was 3 +/- 6 kg).This retrospective chart review suggests that aripiprazole may be effective and well tolerated for children and adolescents with bipolar disorders. Controlled studies of aripiprazole for the treatment of pediatric bipolar disorder are necessary.
- Published
- 2004
21. Pediatric emotion dysregulation: biological and developmental evidence for a dimensional approach
- Author
-
Chelsea Geise, Stephen M. Strakowski, and Drew H. Barzman
- Subjects
Child and adolescent ,Psychiatry and Mental health ,Child Development ,Adolescent ,Humans ,Affective Symptoms ,Adolescent Development ,Psychology ,Child ,Developmental psychology ,Review article - Abstract
The following review article examines the value of a dimensional approach to research in relation to recent findings of child and adolescent emotion dysregulation. With the publication of the DSM-5, it is important to keep in mind that difficulties in pinpointing causal mechanisms may result from the collective grouping of different emotional deficits by diagnoses. Evidence available from studies examining pediatric emotion dysregulation indicate strengths in the dimensional approach for research, especially in light of developmental changes to neural activations of emotion regulation. Use of a dimensional approach in research appears to be an effective tactic that could pave the way for a better understanding of pediatric emotion dysregulation and thereby elucidate better treatments and outcomes for those with this behavioral deficit, regardless of diagnosis.
- Published
- 2014
22. Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study
- Author
-
Neil P. Mills, Samantha M. Bitter, Melissa P. DelBello, Jeffrey R. Strawn, Kiki D. Chang, Robert K. McNamara, Drew H. Barzman, Stephen M. Strakowski, Michael A. Cerullo, Jeffrey A. Welge, and Caleb M. Adler
- Subjects
Male ,Risk ,medicine.medical_specialty ,Bipolar I disorder ,Bipolar Disorder ,Adolescent ,Anxiety ,Impulsivity ,Article ,Young Adult ,Internal medicine ,medicine ,Humans ,Bipolar disorder ,Prospective Studies ,Psychiatry ,Child ,Biological Psychiatry ,Probability ,Psychiatric Status Rating Scales ,Depression ,medicine.disease ,Antidepressive Agents ,Discontinuation ,Psychiatry and Mental health ,Tolerability ,Disease Progression ,Major depressive disorder ,Female ,medicine.symptom ,Psychology ,Mania - Abstract
OBJECTIVE: Depressive and anxiety disorders are common in youth who are at risk for bipolar disorder (i.e., youth who have at least one parent with bipolar disorder) and antidepressants are commonly prescribed as treatment. However, there are few data regarding the safety and tolerability of antidepressants in this population. Therefore, we sought to prospectively examine the effects of these medications in children and adolescents who are diagnosed with depressive or anxiety disorders and have a parent with bipolar I disorder. METHODS: Youth aged 9-20 years, with at least one parent with bipolar I disorder [high risk (HR)], were recruited (n = 118) and assessed using semi-structured diagnostic interviews. Participants were prospectively evaluated using a modified version of the Longitudinal Interval Follow-up Evaluation to assess changes in affective and anxiety symptoms and were treated naturalistically. RESULTS: Over the course of 43-227 weeks (mean duration of follow-up: 106 ± 55 weeks), 21% (n = 25) of youth had antidepressant exposure and, of these, 57% (n = 12) had an adverse reaction (e.g., irritability, aggression, impulsivity, or hyperactivity) that led to antidepressant discontinuation. Those patients who experienced an adverse reaction were significantly younger than those who did not (p = 0.02) and discontinuation of antidepressant therapy secondary to an adverse event occurred at an average of 16.7 ± 17.4 weeks (median: 11 weeks, range: 2-57 weeks). Cox proportional hazard analyses yielded a hazard ratio of 0.725 (p = 0.03), suggesting that there is a 27% decrease in the likelihood of an antidepressant-related adverse event leading to discontinuation with each one-year increase in age. CONCLUSIONS: Antidepressant medications may be poorly tolerated in youth with a familial risk for developing mania. Controlled studies further assessing treatments for depression and anxiety in HR youth are urgently needed. Language: en
- Published
- 2013
23. 26.1 GRAY AND WHITE MATTER VOLUME ALTERATIONS IN YOUTH OFFSPRING OF PARENTS WITH BIPOLAR DISORDER
- Author
-
Caleb M. Adler, Melissa P. DelBello, Fabiano G. Nery, Wade Weber, Drew H. Barzman, Jeffrey A. Welge, Stephen M. Strakowski, Jeffrey R. Strawn, and Thomas J. Blom
- Subjects
White matter ,Psychiatry and Mental health ,medicine.medical_specialty ,medicine.anatomical_structure ,Offspring ,Developmental and Educational Psychology ,medicine ,Bipolar disorder ,Psychology ,Psychiatry ,medicine.disease ,Gray (horse) ,Clinical psychology - Published
- 2016
24. 6.3 EXAMINING THE TIME TREND OF AGGRESSION ON CHILD AND ADOLESCENT PSYCHIATRIC INPATIENT UNITS
- Author
-
Drew H. Barzman, Daniel Lin, Douglas Mossman, Ashaki Warren, and Michael T. Sorter
- Subjects
Child and adolescent ,Psychiatry and Mental health ,medicine.medical_specialty ,Aggression ,Developmental and Educational Psychology ,Inpatient units ,medicine ,Child and adolescent psychiatry ,medicine.symptom ,Psychiatry ,Psychology ,Clinical psychology - Published
- 2016
25. Oppositional Defiant Disorder and Conduct Disorder
- Author
-
Daniel A. Vogel and Drew H. Barzman
- Subjects
Psychotherapist ,Conduct disorder ,Oppositional defiant ,medicine ,Psychology ,medicine.disease - Published
- 2008
26. A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania
- Author
-
Jeffrey A. Welge, Erik Nelson, Caleb M. Adler, Stephen M. Strakowski, Kevin E. Stanford, Melissa P. DelBello, Robert A. Kowatch, and Drew H. Barzman
- Subjects
Divalproex ,Male ,Pediatrics ,medicine.medical_specialty ,Dibenzothiazepines ,Bipolar I disorder ,Bipolar Disorder ,Adolescent ,medicine.drug_class ,Pilot Projects ,Young Mania Rating Scale ,Quetiapine Fumarate ,Double-Blind Method ,mental disorders ,Developmental and Educational Psychology ,medicine ,Humans ,Bipolar disorder ,Psychiatry ,Child ,Valproic Acid ,Mood stabilizer ,Drug Tolerance ,medicine.disease ,Antidepressive Agents ,Psychiatry and Mental health ,Quetiapine ,Female ,medicine.symptom ,Psychology ,Mania ,medicine.drug ,Antipsychotic Agents - Abstract
To determine the comparative efficacy of quetiapine and divalproex for the treatment of adolescent mania.Fifty adolescents (ages 12-18 years) with bipolar I disorder, manic or mixed episode, were randomized to quetiapine (400-600 mg/day) or divalproex (serum level 80-120 microg/mL) for 28 days for this double-blind study, which was conducted from July 2002 through January 2004. The primary efficacy measure was change in Young Mania Rating Scale (YMRS) score across the study period.Repeated measures analysis of variance using the last-observation carried forward data indicated no statistically significant group difference in YMRS scores across the 28 days of the study (p = 0.3). Mixed regression analyses (comparison of slopes) revealed that improvement in YMRS scores occurred more rapidly in the quetiapine than in the divalproex group for both the last-observation carried forward (p = 0.01) and observed data (p = 0.03). Response and remission rates were significantly greater in the quetiapine than in the divalproex group (p.03). Rates of adverse events did not differ significantly between groups.The results suggest that quetiapine is at least as effective as divalproex in the treatment of acute manic symptoms associated with adolescent bipolar disorder; however, a quicker reduction of manic symptoms may occur with quetiapine as compared with divalproex. Quetiapine may be useful as monotherapy for the treatment of adolescents with manic or mixed episodes, although placebo-controlled studies are necessary.
- Published
- 2006
27. Adjunctive topiramate in hospitalized children and adolescents with bipolar disorders
- Author
-
Robert A. Kowatch, Stephen M. Strakowski, Juliet Warner, Kevin E. Stanford, Melissa P. DelBello, Drew H. Barzman, John P. Daniels, Dana L. Rofey, and Katherine Rappaport
- Subjects
Topiramate ,Male ,medicine.medical_specialty ,Bipolar Disorder ,Adolescent ,Medical record ,Fructose ,Hospitalization ,Psychiatry and Mental health ,Treatment Outcome ,Antimanic Agents ,Pediatrics, Perinatology and Child Health ,Adjunctive treatment ,medicine ,Humans ,Pharmacology (medical) ,Anticonvulsants ,Drug Therapy, Combination ,Female ,Psychiatry ,Psychology ,Child ,medicine.drug ,Retrospective Studies - Abstract
The aim of this study was to assess topiramate as adjunctive treatment in children and adolescents hospitalized with bipolar disorders.Medical records of all children and adolescents with a Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV-TR) (APA, 2000) diagnosis of bipolar disorder, type I, hospitalized for an acute manic, mixed, or depressive episode, were reviewed. The primary outcome measure was the Clinical Global Impression-Severity (CGI-S) score.Twenty-five (25) children and adolescents received topiramate, with a mean final dose of 126 mg/day (range, 25-350 mg). Overall CGI-S scores significantly improved from 5.3+/-1.0 to 3.5+/-0.7, and mania CGI-S scores decreased from 5.4+/-1.0 to 3.3+/-0.9. Sixteen (16) of 25 (64%) bipolar patients were classified as responders (defined by an endpoint overall CGI-I score of less than or equal to 2). No serious adverse events occurred during treatment. Of 25 patients evaluated, 1 (4%) experienced mild sedation while treated with topiramate.Preliminary results of this retrospective chart review suggest that adjunctive topiramate may be associated with improvements in children and adolescents hospitalized for an acute manic, mixed, or depressive episode. Randomized and controlled trials with adjunctive topiramate in this population are needed to further explore this observation.
- Published
- 2005
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.